Peptide directorySkin, immune & repair

Thymosin beta-15

A thymosin of prostate cancer, studied as a marker of how far it spreads.

Where it comes from

Made in
Sparse in normal adult tissue; high in prostate, breast and lung cancers and in the developing brain
Sent out by
Mostly intracellular
Acts on
  • Actin
  • Motile cancer cells

What it does

  • Speeds cell migration, so cancer cells that make it spread
  • A marker that distinguishes aggressive from indolent prostate cancer in research
  • Function in healthy tissue unknown

In medicine

  • A research marker only: in the paper that named it, human prostate tumours made more of it as the Gleason grade rose, and blocking it slowed the most motile rat cancer cells 1
  • No medicine, and no test using it has entered clinical use

Beyond the body’s own use

  • Not a treatment and not in trials. What is asked of it is whether it could grade a prostate cancer better than the measures already in use, which matters because most prostate cancers never need treating 1
  • Two nearly identical genes on the X chromosome make it, so an assay cannot easily say which of them a sample came from, and what it does in healthy tissue is still unknown

Sources

  1. Bao et al., Thymosin beta 15: a regulator of tumour cell motility in metastatic prostate cancer, Nature Medicine 1996

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.